Stock News & Analysis

Enbridge is a Canadian midstream giant, but it comes with an interesting twist.

Rivian received a vote of confidence and a boost in stock price recently. Here's why there could be more room to run.

Could Crocs be more than just a fad? Join us as we evaluate the company's strengths and weaknesses, and discover if this stock is a hidden gem waiting to be uncovered.

Camtek just printed its strongest quarter ever, but one investor quietly took chips off the table, and the timing says a lot about how professionals think after big semiconductor rallies.

With Huntsman trading near multi-year lows, one manager appears to be betting that cash flow and restructuring matter more than near-term earnings pain.

Two analysts waxed bullish on the future of the company.

This high-yielding stock faces some near-term challenges.

With energy prices swinging and capital discipline under pressure, one manager is quietly dialing back risk in a stock that has punished even patient holders.

This biotech innovator in inhaled therapeutics reported a notable insider sale amid ongoing product development and licensing activity.

With cash piling up, debt rolling off, and shareholder returns accelerating, one small fund is stepping into a battered energy name at a moment when the fundamentals look steadier than the stock.

Emerging market equities bounced back in a big way in 2025, highlighting the advantages of this cheap-to-own Vanguard ETF.

The company has promising technology, but will it be commercially viable?

The company just might have a winner on its hands with a pipeline heart disease treatment.

USA Rare Earth could be shaping up for a game-changing year in 2026.

If you are looking for high yields, this drug maker and this device maker are both worth a deep dive today.

This company is expected to deliver solid, yet unspectacular, growth in 2026.

The company is on the brink of commercializing a unique medication.

Both stocks are reeling this year, but one has a much clearer path to glory.

This connected fitness company, known for its subscription model, reported a notable insider sale amid a year of share price declines.

This may be a good time to start accumulating shares.